NEOLA — Neola Medical AB Income Statement
0.000.00%
Last trade - 00:00- SEK86.91m
- SEK60.40m
Annual income statement for Neola Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.031 | 0.625 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 1.54 | 9.05 | 8.02 | 8.02 | 8.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.75 | 7.28 | 10.4 | 9.62 | 10.8 |
| Operating Profit | -6.72 | -6.65 | -10.4 | -9.62 | -10.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.72 | -6.65 | -10.4 | -9.01 | -10.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.72 | -6.65 | -10.4 | -9.01 | -10.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.72 | -6.65 | -10.4 | -9.01 | -10.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.72 | -6.65 | -10.4 | -9.01 | -10.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.734 | -0.366 | -0.397 | -0.162 | -0.143 |
| Dividends per Share |